Table 5.
Unadjusted | Adjusted* | |||
---|---|---|---|---|
Odds Ratio (95% CI) |
p-value | Odds Ratio (95% CI) |
p-value | |
Age, years | 1.02 (0.99, 1.05) | 0.251 | 1.02 (0.99, 1.06) | 0.261 |
Women | 1.50 (1.03, 2.17) | 0.034 | 1.31 (0.89, 1.94) | 0.167 |
African-American | 1.38 (0.96, 1.99) | 0.087 | 1.20 (0.81, 1.77) | 0.370 |
Mean SBP, mmHg | 1.05 (1.03, 1.06) | <0.001 | 1.04 (1.03, 1.06) | <0.001 |
Mean pulse pressure, mmHg | 1.04 (1.02, 1.05) | <0.001 | 0.99 (0.96, 1.02) | 0.627 |
Diabetes mellitus | 0.94 (0.66, 1.33) | 0.717 | 0.95 (0.66, 1.38) | 0.796 |
History of myocardial infarction | 0.87 (0.53, 1.44) | 0.597 | 0.97 (0.58, 1.64) | 0.914 |
History of stroke | 0.84 (0.52, 1.37) | 0.488 | 0.95 (0.57, 1.58) | 0.845 |
History of heart failure | 0.73 (0.38, 1.39) | 0.341 | 0.83 (0.43, 1.62) | 0.585 |
Antihypertensive medication class | ||||
ACE Inhibitors | 0.93 (0.65, 1.33) | 0.691 | 0.97 (0.67, 1.40) | 0.862 |
Beta blockers | 1.19 (0.83, 1.70) | 0.347 | 1.25 (0.86, 1.82) | 0.234 |
Calcium channel blockers | 1.29 (0.91, 1.84) | 0.158 | 1.08 (0.74, 1.56) | 0.711 |
Angiotensin receptor blockers | 1.73 (1.20, 2.50) | 0.004 | 1.58 (1.07, 2.32) | 0.020 |
Diuretics | 0.93 (0.64, 1.34) | 0.698 | 0.85 (0.58, 1.24) | 0.400 |
Low reproducibility was defined as an absolute difference in the standard deviation of systolic blood pressure ≥ 8 mmHg between the first seven and second measurements. This outcome was observed in 20.0% (N=154) patients.
Adjusted for age, gender, race, and mean systolic blood pressure